Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A
出版年份 2016 全文链接
标题
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 101, Issue 4, Pages 519-530
出版商
Wiley
发表日期
2016-12-10
DOI
10.1002/cpt.525
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin
- (2016) P Stopfer et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans
- (2015) Nicolas Hohmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies
- (2015) Lichuan Liu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug–Drug Interactions in a Clinical Setting—Proposal of a Four Component Transporter Cocktail
- (2015) Thomas Ebner et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects
- (2014) Sreeneeranj Kasichayanula et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin
- (2014) Thomayant Prueksaritanont et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling
- (2014) Sieto Bosgra et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
- (2013) Thomayant Prueksaritanont et al. AAPS Journal
- Physiologically based pharmacokinetic modelling andin vivo[I]/Kiaccurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate
- (2013) Yuansheng Zhao et al. BRITISH JOURNAL OF PHARMACOLOGY
- In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development
- (2013) K L R Brouwer et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of a single-dose rifampin on the pharmacokinetics of pitavastatin in healthy volunteers
- (2013) Yao Chen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A semi-mechanistic absorption model to evaluate drug-drug interaction with dabigatran: application with clarithromycin
- (2012) Xavier Delavenne et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Transporter-Mediated Drug–Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies
- (2012) K Yoshida et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver
- (2012) Evita van de Steeg et al. JOURNAL OF CLINICAL INVESTIGATION
- Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study
- (2011) K Maeda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study
- (2011) K Maeda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prediction of the Overall Renal Tubular Secretion and Hepatic Clearance of Anionic Drugs and a Renal Drug-Drug Interaction Involving Organic Anion Transporter 3 in Humans by In Vitro Uptake Experiments
- (2011) T. Watanabe et al. DRUG METABOLISM AND DISPOSITION
- Effect of Cytochrome P450 3A5 Genotype on Atorvastatin Pharmacokinetics and Its Interaction with Clarithromycin
- (2011) Jaekyu Shin et al. PHARMACOTHERAPY
- Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data
- (2010) I Templeton et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism
- (2009) Yi-Jing He et al. CLINICA CHIMICA ACTA
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Physiologically Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
- (2009) S. K. Quinney et al. DRUG METABOLISM AND DISPOSITION
- Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
- (2009) Ichiro Ieiri et al. Expert Opinion on Drug Metabolism & Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started